Related by context. All words. (Click for frequent words.) 63 NEUMUNE 63 GvHD 63 CBLB# 63 Protexia R 62 MultiStem 62 PROCHYMAL 62 methylnaltrexone 61 GVAX 61 OncoVEX GM CSF 61 Tamibarotene 61 FOLOTYN 61 Mipomersen 61 Amrubicin 61 ACZ# 61 Azedra 61 Urocidin 60 OncoVEX 60 UPLYSO 60 PEG Interferon lambda 60 prGCD 60 Revimmune 60 TREANDA 60 amrubicin 60 elotuzumab 60 CoFactor 60 MAXY G# 60 Corlux 59 JAK inhibitor 59 INCB# [002] 59 dacetuzumab 59 Cethrin 59 YONDELIS 59 Perifosine 59 HuMax CD# 59 Archexin 59 glufosfamide 59 Traficet EN 59 orBec 59 perifosine 59 Provacel 59 CIMZIA TM 59 Anthim 59 Folotyn 59 blinatumomab 59 voreloxin 59 elacytarabine 59 Chrysalin 59 Viprinex 59 Fibrin Pad 59 lomitapide 59 eniluracil 59 MyVax 59 ELACYT 59 StemEx 59 axitinib 59 Bezielle 59 Dacogen injection 59 Restanza 59 BAY #-# 58 ISIS # 58 OHR/AVR# 58 KRN# 58 OvaRex ® MAb 58 aflibercept 58 PROSTVAC TM 58 Acute Radiation Syndrome ARS 58 C1 INH 58 Pirfenidone 58 Neuradiab 58 IRX 2 58 daclizumab 58 Serdaxin 58 Phenoptin 58 Jevtana 58 Telcyta 58 Radilex 58 teduglutide 58 SomatoKine 58 EOquin TM 58 tanespimycin 58 Alpharadin 58 ADVEXIN 58 FavId 58 ACTEMRA 58 TroVax 58 Combidex 58 Virulizin ® 57 visilizumab 57 Chemophase 57 Campath alemtuzumab 57 reslizumab 57 dexanabinol 57 Amigal 57 Cotara 57 MYDICAR ® 57 Advexin 57 phase IIb clinical 57 teplizumab 57 evaluating Prochymal 57 Evoltra 57 Dapagliflozin 57 picoplatin 57 CYT# 57 AP# [003] 57 Diamyd ® 57 Protectan CBLB# 57 investigational drug 57 Icatibant 57 Panitumumab 57 recurrent GBM 57 steroid refractory 57 Amplimexon 57 BEXXAR 57 lumiliximab 57 Advagraf 57 rilonacept 57 alemtuzumab 57 Zelrix 57 THALOMID 57 neurogenic orthostatic hypotension 57 maribavir 57 eculizumab 57 CIMZIA ™ 57 BiovaxID 57 Androxal 57 MGCD# [001] 57 CANCIDAS 57 phase IIa clinical 57 HuMax CD4 57 AEGR 57 HQK 57 celgosivir 57 CCX# 57 Vidaza 57 TELCYTA 57 PEG INTRON 57 pomalidomide 57 XL# [003] 57 XGEVA 57 mapatumumab 57 galiximab 57 rhThrombin 57 Treatment IND 57 ozarelix 57 CINTREDEKIN BESUDOTOX 57 VIDAZA 57 rituximab Rituxan 57 taliglucerase alfa 57 IV Busulfex 57 Phase 2b trial 57 pralatrexate 57 steroid refractory GvHD 57 ELND# 57 Xcytrin 57 DCVax R Brain 57 regadenoson 57 TYZEKA 57 Hycamtin 57 Prochymal TM 56 ZEVALIN 56 Marqibo 56 Genasense ® 56 voclosporin 56 rFVIIIFc 56 canakinumab 56 aprepitant 56 thymalfasin 56 Tovaxin 56 clofarabine 56 Nexavar ® 56 Romiplostim 56 Proxinium TM 56 Denosumab 56 BrachySil TM 56 SinuNase 56 Asentar 56 PROVENGE 56 Dacogen 56 alvimopan 56 Nplate 56 RSD# 56 PROMACTA 56 tesmilifene 56 bevacizumab Avastin 56 ganetespib 56 Androxal TM 56 XmAb# 56 riociguat 56 Octreolin 56 Ketotransdel 56 Canvaxin 56 Fludara 56 sunitinib malate 56 terlipressin 56 TACI Ig 56 otelixizumab 56 TNFerade 56 ixabepilone 56 VAPRISOL 56 T DM1 56 ularitide 56 Allovectin 7 ® 56 lintuzumab 56 iniparib 56 Neumune 56 Vilazodone 56 rBChE 56 Daclizumab 56 Phase Ib 56 lupus nephritis 56 Civacir 56 MNTX 56 mipomersen 56 cethromycin 56 Alocrest 56 Golimumab 56 Degarelix 56 PXD# 56 panitumumab 56 tolerability profiles 56 RECOTHROM 56 investigational monoclonal antibody 56 huC# DM4 56 Gleevec imatinib mesylate 56 invasive aspergillosis 56 YERVOY 56 NV1FGF 56 HoFH 56 decitabine 56 MYDICAR 56 GSK# [001] 56 Vectibix 56 vosaroxin 56 PLX cells 56 Soliris 56 BRAF inhibitor 56 Fabry Disease 56 Specifid 56 Arcalyst 56 Ixempra 56 ACTEMRA TM 56 Tavocept 56 adult chronic ITP 56 relapsing multiple sclerosis 56 dalbavancin 56 telaprevir 56 Numax 56 Doxil 56 Alfimeprase 56 Ceflatonin 56 INCB# [001] 55 EFAPROXYN 55 omacetaxine 55 StemEx R 55 standard chemotherapy regimen 55 TNF antagonist 55 Omacetaxine 55 Cetrorelix 55 tamibarotene 55 EndoTAG TM -1 55 RG# [001] 55 vilazodone 55 LC#m# 55 azacitidine 55 ATL# [001] 55 cediranib 55 NP2 Enkephalin 55 DASISION 55 sapacitabine 55 ataluren 55 nimotuzumab 55 ImClone Erbitux 55 enzastaurin 55 MyVax R 55 HER2 positive metastatic breast 55 rituximab 55 rFVIIa 55 Stimuvax 55 Phase 2a trial 55 Rilonacept 55 Onconase 55 denosumab 55 Campath 55 ThGRF 55 ZOLINZA 55 Clolar 55 Genasense 55 MyoCell 55 ruxolitinib 55 BioNumerik 55 TORISEL 55 urocortin 2 55 Everolimus 55 oral deforolimus 55 MGd 55 Allovectin 7 55 ATryn ® 55 RAPTIVA 55 trastuzumab DM1 T DM1 55 ostarine 55 IL# PE#QQR 55 rhIGF-I/rhIGFBP-3 55 torezolid phosphate 55 VEGF Trap 55 clinical trial 55 Zolinza 55 Pixantrone 55 BYDUREON 55 SparVax TM 55 Xanafide 55 Virulizin R 55 StaphVAX 55 GGF2 55 everolimus 55 TBC# 55 MOZOBIL 55 KNS # 55 liposomal formulation 55 Temsirolimus 55 alfimeprase 55 satraplatin 55 talactoferrin 55 TheraSphere 55 SNT MC# 55 rindopepimut 55 acute GvHD 55 sorafenib tablets 55 Phase IIa clinical 55 cilengitide 55 Rituxan 55 Ataluren 55 Phase III clinical 55 Aplidin 55 romiplostim 55 gastrointestinal stromal tumors GIST 55 AEG# 55 Cimzia TM 55 rhC1INH 55 TELINTRA 55 SUTENT 55 dirucotide 55 romidepsin 55 bafetinib 55 PREOS R 55 OPAXIO 55 Methylnaltrexone 55 Aurexis 55 Firazyr 55 Tekamlo 55 Rezular 55 acute HAE attacks 55 Cloretazine R VNP#M 55 baminercept 55 Neurodex 55 Aflibercept 55 Acetavance 55 valopicitabine 55 clevidipine 55 drug ISA# 55 sunitinib 55 Ambrisentan 55 eosinophilic asthma 55 dose cohorts 55 proteasome inhibitor 55 tremelimumab 55 relapsed multiple myeloma 55 APF# 55 Cellegesic 55 Bifeprunox 55 darapladib 55 Ranexa 55 HGS ETR1 55 pegylated interferon alfa 55 L BLP# 55 Oncophage 55 Carfilzomib 55 Genz # 55 mycophenolate mofetil 55 ASONEP 55 Gemzar ® 55 abiraterone 55 palonosetron 55 Alemtuzumab 55 Sutent sunitinib 55 dirucotide MBP# 55 custirsen 55 Actemra 55 iloperidone 54 ALN TTR 54 ZYBRESTAT 54 ATryn R 54 Fibrillex TM 54 Cimzia ® 54 Cleveland BioLabs 54 Allovectin 7 R 54 pseudobulbar affect PBA 54 bortezomib Velcade 54 TRISENOX 54 zileuton 54 G#DT 54 Vivaglobin 54 Bortezomib 54 motesanib 54 Factor VIIa 54 SPIRIVA HandiHaler 54 nalbuphine ER 54 vismodegib 54 REVLIMID 54 BARACLUDE R 54 Viramidine 54 Abraxane 54 Peramivir 54 oxymorphone ER 54 MAGE A3 ASCI 54 LymphoStat B 54 low dose cytarabine 54 PS# [001] 54 relapsed MM 54 Dasatinib 54 Velcade bortezomib 54 PEG SN# 54 synthetic retinoid 54 Nexavar 54 Nanobody 54 esophageal candidiasis 54 PSMA ADC 54 anidulafungin 54 PF # [001] 54 chronic angina 54 anti CD3 antibody 54 Cethromycin 54 Chondrogen 54 active comparator 54 icatibant 54 bardoxolone 54 Plicera 54 Noxafil 54 MEK inhibitors 54 paliperidone ER 54 Vandetanib 54 Telaprevir 54 Amgen Vectibix 54 Eculizumab 54 ponatinib 54 REOLYSIN ® 54 Amitiza 54 investigational compounds 54 vemurafenib 54 plus dexamethasone 54 DEB# 54 ZADAXIN 54 Zerenex 54 Fodosine 54 Rescula 54 Lenocta 54 vernakalant 54 eprotirome 54 Phase #b/#a 54 Irinotecan 54 placebo controlled clinical 54 Kuvan 54 Homspera 54 Valortim 54 tafamidis 54 HUMIRA 54 isavuconazole 54 Cx# [002] 54 BLA filing 54 HuLuc# 54 PTK ZK 54 Mozobil 54 HuMax EGFr 54 OvaRex R 54 LEVADEX 54 Omigard 54 basiliximab 54 invasive candidiasis 54 CYCLOSET 54 Phase IIB 54 Sym# 54 Treanda 54 Junovan 54 Locteron 54 recurrent glioma 54 investigational compound 54 ReN# 54 PREOS 54 Ereska 54 Triolex 54 refractory angina 54 Targretin 54 Proleukin 54 atacicept 54 Nuvion 54 Adlea 54 Azixa 54 diabetic neuropathic pain 54 pegylated interferon alpha 54 Increlex R 54 Phase III 54 Altastaph 54 Apoptone 54 TAXUS Stent 54 phase IIb trial 54 oral antiviral 54 teriflunomide 54 FOLOTYN ® 54 ThermoDox R 54 L MTP PE 54 Reolysin 54 IMiDs 54 vorinostat 54 Behcet uveitis 54 Zadaxin 54 Onalta 54 deforolimus 54 Sulonex TM 54 Revascor TM 54 vandetanib 54 G CSF 54 liprotamase 54 Ceflatonin R 54 INC# 54 ISTODAX 54 Orphan Status 54 hematopoietic cell 54 dimebon 54 Ampligen 54 ALN TTR# 54 Erbitux 54 fluvastatin 54 randomized multicenter Phase III 54 MAP# 54 Ostarine 54 BLA submission 54 Nexavar sorafenib 54 tipranavir 54 telbivudine 54 sipuleucel T 54 multiple myeloma MM 54 hA# 54 Milnacipran 54 omecamtiv mecarbil 54 iclaprim 54 mertansine 54 efficacy tolerability 54 MYCAMINE 54 TAXUS TM 54 Elotuzumab 54 PRTX 54 Zemplar Capsules 54 Ilaris 54 preclinical efficacy 54 Prodarsan ® 54 pradefovir 54 B CLL 54 NATRECOR R 54 Ipilimumab 54 epratuzumab 54 LEVADEX ™ 54 Genasense ® oblimersen 54 DP b# 54 RIGScan CR 54 Gliadel Wafer 54 Leukine 54 LEUKINE 54 Increlex 54 Novartis Zometa 54 registrational 54 posaconazole 54 bavituximab 54 Cimzia R 54 VELCADE 54 HCD# [002] 54 Dacogen decitabine 54 Granulocyte Colony Stimulating Factor 54 TAXUS Element Stent System 54 pivotal Phase III 54 urokinase 54 Acute Radiation Syndrome 53 Omapro 53 Pivotal Trial 53 Iloperidone 53 bicifadine 53 investigational 53 GVAX immunotherapy 53 MBP# [001] 53 pertuzumab 53 DXL# 53 Mylotarg 53 Zenvia Phase III 53 aflibercept VEGF Trap 53 phase IIa 53 E2F Decoy 53 lubiprostone 53 Rituxan rituximab 53 Erlotinib 53 milatuzumab 53 Vitaxin 53 IMC A# 53 ALN RSV# 53 Aryplase 53 Catena ® 53 cathepsin K inhibitor 53 ospemifene 53 Sorafenib 53 CIMZIA TM certolizumab pegol 53 rNAPc2 53 NUVIGIL 53 AGGRASTAT ® 53 Phase Ib II 53 Arimoclomol 53 HepaGam B 53 ADAGIO study 53 Clolar ® 53 ASA# 53 anticancer therapy 53 post menopausal osteoporosis 53 Veronate 53 Orapred ODT 53 Phase 1b trial 53 EVIZON 53 talabostat 53 Cloretazine 53 ALN VSP 53 alvespimycin 53 liposomal doxorubicin 53 Octreotide 53 Laquinimod 53 gefitinib Iressa 53 Xinlay 53 oxypurinol 53 RSR# 53 Phase III Pivotal 53 TAXUS Liberte Stent 53 Pimavanserin 53 relapsed ovarian cancer 53 PrevOnco 53 indolent NHL 53 Actemra tocilizumab 53 acyclovir Lauriad R 53 Bicifadine 53 TYGACIL 53 randomized Phase 53 Oncaspar 53 Natalizumab 53 Nicole Onetto MD 53 cancer immunotherapies 53 imetelstat 53 REMINYL ® 53 motavizumab 53 AzaSite Plus 53 OMNARIS HFA 53 StaphVax 53 CD# antibody [001] 53 Vascugel 53 Gleevec resistant 53 CR# vcMMAE 53 velaglucerase alfa 53 pemetrexed Alimta 53 BCR ABL inhibitor 53 apaziquone 53 ERBITUX 53 PEG PAL 53 Increlex ® 53 severe hypercholesterolemia 53 Rivaroxaban 53 Fibrillex 53 refractory gout 53 Phase 1b clinical 53 monotherapy 53 Empatic 53 dose cohort 53 Troxatyl 53 SEPET TM 53 MACUGEN 53 Cimzia ® certolizumab pegol 53 edifoligide 53 Dacetuzumab 53 forodesine 53 ADVEXIN clinical 53 antiangiogenic therapy 53 PLX PAD 53 GALNS 53 Genentech Roche 53 Protexia ® 53 Northera 53 incyclinide 53 obatoclax 53 SinuNase TM 53 Tarvacin 53 Cinryze 53 Epratuzumab 53 BEMA TM Fentanyl 53 metastatic castration resistant 53 Panzem R 53 phase IIb 53 Gleevec imatinib 53 PLX# 53 Prestara 53 Tarceva TM 53 Phase IIb 53 Panzem R NCD 53 Tarceva 53 mild vasodilator 53 Soliris TM eculizumab 53 IMGN# 53 PHX# 53 PrevOnco ™ 53 Exelon Patch 53 RhuDex ® 53 metaglidasen 53 Fampridine SR 53 Phase IIIb clinical 53 abiraterone acetate 53 Personalized Immunotherapy 53 Phase Ib clinical 53 Lung Rx 53 Darusentan 53 acute ischemic stroke 53 Gralise 53 GAMMAGARD 53 BENLYSTA 53 lapatinib Tykerb 53 DCVax R 53 tolevamer 53 Ontak 53 temsirolimus 53 tasocitinib 53 TKM ApoB 53 Phase IIa trial 53 Fablyn 53 BRIM2 53 Zybrestat 53 schizophrenia CIAS 53 JANUVIA 53 Rasagiline 53 topical NSAID 53 bendamustine 53 Cloretazine ® 53 ambrisentan 53 TEMODAL 53 Genasense R 53 Anti TNF 53 NKTR 53 Indaflex TM 53 Ceplene 53 calcineurin inhibitors 53 docetaxel Taxotere ® 53 samalizumab 53 Rhucin 53 Cardio Vascu Grow 53 Gleevec Glivec 53 HspE7 53 R sorafenib tablets 53 Tengion Neo Urinary Conduit 53 NTx TM -# 53 DAVANAT ® 53 ecallantide 53 Kepivance 53 TriRima 53 FOLFOX4 53 AGGRASTAT R 53 pain palliation 53 Abatacept 53 Phase IIb clinical trials 53 oxaliplatin Eloxatin 53 DR Cysteamine 53 LymphoStat B belimumab 53 DAVANAT R 53 Muraglitazar 53 Cladribine Tablets 53 Phase 1b 53 Azedra TM 53 Syncria 53 6R BH4 53 ustekinumab 53 INTERCEPT platelets 53 ruboxistaurin 53 pegylated interferons 53 ocrelizumab 53 hepatitis C HCV 53 Imprime PGG 53 veltuzumab 53 Bioral ® 53 R#/MEM # 53 metastatic castrate resistant 53 mCRC patients 53 selective androgen receptor modulator 53 LAF# 53 metastatic hormone refractory 53 BNC# 53 Liprotamase 53 radiation sensitizer 53 MDV# 53 Tolvaptan 53 placebo controlled Phase 53 LE DT 53 Interferon alpha 53 superficial bladder cancer 53 registrational trial 53 ONCONASE R 53 sirolimus 53 Vicinium TM 53 Liprostin 53 tecarfarin 53 SNT-MC#/idebenone 53 GW# [003] 53 Navelbine ® 53 Etanercept 53 Posidur 53 pegloticase 53 Acapodene 53 PLK1 SNALP 53 Tarvacin TM 53 ADXS# 53 natalizumab 53 bazedoxifene 53 faropenem 53 Pfizer Sutent 53 CIP ISOTRETINOIN 53 ORENCIA ® 53 PRADAXA 53 dose escalation clinical 53 HEPLISAV 53 Hollis Eden 53 Bevacizumab 53 IPLEX 53 Phase IIb clinical 53 Ventavis 53 sorafenib Nexavar 53 alemtuzumab MS 53 NEBIDO 53 FTY# 53 EDEMA3 53 tesetaxel 53 HuCNS SC cells 53 Treximet 53 pharmacokinetic PK study 53 PRT# 53 Trexima 53 Xyotax 53 FENTORA 53 Ampligen R 52 Phase #/#a 52 ELADUR 52 bosutinib 52 NEUPOGEN 52 oral rivaroxaban 52 acute coronary syndromes ACS 52 Revlimid lenalidomide 52 monoclonal antibody 52 Onrigin 52 chemotherapy induced neutropenia 52 ImmuKnow 52 OMS#HP 52 docetaxel 52 Vibativ 52 tocilizumab 52 Hepatocellular Carcinoma HCC 52 PhosLo 52 ORMD 52 milnacipran 52 topotecan 52 pitavastatin 52 Promacta 52 Ophena TM 52 BrachySil 52 Curaxin CBLC# 52 USL# 52 TG# [003] 52 Arranon 52 pexelizumab 52 BEMA Fentanyl 52 Dalbavancin 52 cannabinor 52 Bendamustine 52 Zarnestra 52 Nimotuzumab 52 APPRAISE 52 Gattex 52 Microplasmin 52 tezampanel 52 Ramelteon 52 Campath ® 52 ZOSTAVAX 52 Engerix B 52 Xcellerated T Cells 52 eritoran 52 ROTATEQ 52 erlotinib Tarceva ® 52 Plasmin 52 multicenter clinical 52 APOPTONE 52 Initiate Clinical Trial 52 #ME# 52 Arzerra 52 ALKS 52 GATTEX 52 AEOL # 52 IMA# 52 PRX# 52 HGS ETR2 52 velafermin 52 MabCampath 52 Zenvia 52 Bronchitol 52 Urocortin 2 52 Adalimumab 52 Phase 2b study 52 Durezol 52 Pivotal Phase III 52 eltrombopag 52 vidofludimus 52 Aliskiren 52 Xigris 52 Focalin XR 52 PROVENGE sipuleucel T 52 PI3K/Akt pathway inhibitor 52 Tolamba 52 Apixaban 52 REPLAGAL 52 DPX Survivac 52 DOXIL 52 Trofex 52 Zilver PTX 52 Uplyso 52 TRV# [001] 52 Bucindolol 52 ORENCIA R 52 relapsed ALL 52 gabapentin enacarbil 52 interferon beta 52 Clofarabine 52 Fusilev 52 dexpramipexole 52 Telintra 52 subcutaneous formulation 52 chlorambucil 52 Plenaxis TM 52 Intermezzo R 52 Targretin capsules 52 rFIXFc 52 PNH patients 52 Motesanib 52 TRIOLEX 52 linaclotide 52 Phase Ib study 52 ofatumumab 52 Neupogen ® 52 randomized Phase 2b 52 zalutumumab 52 Taxus Liberte 52 Phase III HEAT 52 hormone refractory prostate cancer 52 ARCALYST 52 Tocosol Paclitaxel 52 retigabine 52 Argatroban 52 refractory APL 52 Diabetic Macular Edema 52 Proellex TM 52 ReoPro 52 albinterferon alfa 2b 52 Canvaxin TM 52 Silodosin 52 Abiraterone acetate 52 CORLUX 52 relapsed refractory multiple myeloma 52 ThermoDox ® 52 Evoltra TM 52 palifermin 52 Raptiva ® 52 Flutiform TM 52 CIP TRAMADOL ER 52 TRAIL receptor antibodies 52 ThermoDox 52 TOLAMBA 52 pegylated liposomal doxorubicin 52 refractory indolent non 52 Cimzia 52 carfilzomib 52 Ocrelizumab 52 neratinib 52 fenofibric acid 52 Virulizin 52 AQ4N 52 refractory CLL 52 Horizant 52 indiplon capsules 52 Cinryze TM 52 Q#IR 52 Onco TCS 52 Solid Tumors 52 Augment Injectable 52 patients evaluable 52 investigational therapies 52 Plenaxis R 52 Torisel